Dr. Zhou is a chief physician and doctoral supervisor. She was a visiting scholar at Johns Hopkins Hospital from 2014 to 2015. She experts in diagnosis and treatment of common and difficult lung diseases, and she is also an active promoter for individualized and precise treatment of lung cancer. Dr. Zhou has rich clinical experience in immunotherapy of lung cancer, driver gene and related targeted therapy, overcoming drug resistance and adverse reaction management, etc. She propels the basic clinical transformation of molecular targeted therapy for lung cancer and participates in many international multicenter clinical studies of new drugs.

Accurate treatment of lung cancer, immunotherapy, research of small molecule targeted drugs and exploration of drug resistance mechanism; basic clinical transformation of lung diseases

Director of Chinese Society of Clinical Oncology (CSCO) and Member of Special Committee of Non-small Cell Lung Cancer;

Member of Tobacco Diseases Group of Respiratory Branch of Chinese Medical Association;

Commissioner for new drug evaluation of State Food and Drug Administration;

Member of Chest Tumor Branch of China Medical Association;

Member of Clinical Ethics Group of Medical Ethics Branch of Chinese Medical Association;

Member of the Special Committee on Clinical Research of Cancer Drugs of China Anti-cancer Association;

Member of Lung Cancer Group of Respiratory Branch of Zhejiang Medical Association;

Member of the Professional Committee of Tumor Markers of Zhejiang Anti-cancer Association;

Member of International Lung Cancer Research Association (IASLC);

Member of American Society of Clinical Oncology (CSCO).